WHO Approves Sinopharm COVID-19 Vaccine's Effectiveness and Safety

Strategic Advisory Group of Experts of the World Health Organization approved the effectiveness and the safety of the Sinopharm vaccine, the group asserted on Tuesday.

This step is described as a step closer to approve the vaccine for emergency use globally. Sinopharm is the first Chinese COVID-19 vaccine to be recommended by the WHO.

The report of the group of experts assured the effectiveness of the two-dose vaccine for adults aged between 18 and 59 years old with 90%.

It added that it is also effective with 91% for people aged over 60 years old.

Moreover, the report asserted that only 74 people from 1.1 million doses suffered from side effects after the vaccination. The observed side effects were mild and they included exhaustion, headache, and fever.

Sinopharm would be the fifth approved COVID-19 vaccine by the international organization.